234 related articles for article (PubMed ID: 27080480)
21. The association between 38 previously reported polymorphisms and psoriasis in a Polish population: High predicative accuracy of a genetic risk score combining 16 loci.
Kisiel B; Kisiel K; Szymański K; Mackiewicz W; Biało-Wójcicka E; Uczniak S; Fogtman A; Iwanicka-Nowicka R; Koblowska M; Kossowska H; Placha G; Sykulski M; Bachta A; Tłustochowicz W; Płoski R; Kaszuba A
PLoS One; 2017; 12(6):e0179348. PubMed ID: 28617847
[TBL] [Abstract][Full Text] [Related]
22. A genetic score can identify men at high risk for prostate cancer among men with prostate-specific antigen of 1-3 ng/ml.
Nordström T; Aly M; Eklund M; Egevad L; Grönberg H
Eur Urol; 2014 Jun; 65(6):1184-90. PubMed ID: 23891454
[TBL] [Abstract][Full Text] [Related]
23. Genetic susceptibility to type 2 diabetes is associated with reduced prostate cancer risk.
Pierce BL; Ahsan H
Hum Hered; 2010; 69(3):193-201. PubMed ID: 20203524
[TBL] [Abstract][Full Text] [Related]
24. Analysis of prostate cancer association with four single-nucleotide polymorphisms from genome-wide studies and serum phyto-estrogen concentrations.
Ho CK; Halley L; Wei J; Habib FK
Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):365-8. PubMed ID: 22733159
[TBL] [Abstract][Full Text] [Related]
25. Literature-based genetic risk scores for coronary heart disease: the Cardiovascular Registry Maastricht (CAREMA) prospective cohort study.
Vaarhorst AA; Lu Y; Heijmans BT; Dollé ME; Böhringer S; Putter H; Imholz S; Merry AH; van Greevenbroek MM; Jukema JW; Gorgels AP; van den Brandt PA; Müller M; Schouten LJ; Feskens EJ; Boer JM; Slagboom PE
Circ Cardiovasc Genet; 2012 Apr; 5(2):202-9. PubMed ID: 22373668
[TBL] [Abstract][Full Text] [Related]
26. Genetic susceptibility to prostate cancer in Taiwan: A genome-wide association study.
Bau DT; Tsai CW; Chang WS; Yang JS; Liu TY; Lu HF; Wang YW; Tsai FJ
Mol Carcinog; 2024 Apr; 63(4):617-628. PubMed ID: 38390760
[TBL] [Abstract][Full Text] [Related]
27. Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.
Liss MA; Xu J; Chen H; Kader AK
Prostate; 2015 Sep; 75(12):1322-8. PubMed ID: 25982801
[TBL] [Abstract][Full Text] [Related]
28. The Role of Genetic Risk Score in Predicting the Risk of Hypertension in the Korean population: Korean Genome and Epidemiology Study.
Lim NK; Lee JY; Lee JY; Park HY; Cho MC
PLoS One; 2015; 10(6):e0131603. PubMed ID: 26110887
[TBL] [Abstract][Full Text] [Related]
29. Joint Effects of GWAS SNPs in Coagulation System Confer Risk to Hypertensive Intracerebral Hemorrhage.
Cao Y; Tian M; Fang Q; Wen Z; Wang W; Ding H; Wang DW
Neuromolecular Med; 2017 Sep; 19(2-3):395-405. PubMed ID: 28718048
[TBL] [Abstract][Full Text] [Related]
30. Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in low-risk Korean men.
Park K; Kim JH; Jeon HG; Byun SS; Lee E
Urology; 2010 Jun; 75(6):1516.e1-7. PubMed ID: 20350746
[TBL] [Abstract][Full Text] [Related]
31. A genetic risk score is associated with polycystic ovary syndrome-related traits.
Lee H; Oh JY; Sung YA; Chung HW
Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
[TBL] [Abstract][Full Text] [Related]
32. Prostate cancer gene 3 score predicts prostate biopsy outcome in men receiving dutasteride for prevention of prostate cancer: results from the REDUCE trial.
Aubin SM; Reid J; Sarno MJ; Blase A; Aussie J; Rittenhouse H; Rittmaster RS; Andriole GL; Groskopf J
Urology; 2011 Aug; 78(2):380-5. PubMed ID: 21820580
[TBL] [Abstract][Full Text] [Related]
33. Type 2 Diabetes Genetic Variants and Risk of Diabetic Retinopathy.
Chong YH; Fan Q; Tham YC; Gan A; Tan SP; Tan G; Wang JJ; Mitchell P; Wong TY; Cheng CY
Ophthalmology; 2017 Mar; 124(3):336-342. PubMed ID: 28038984
[TBL] [Abstract][Full Text] [Related]
34. Genetic predisposition to early recurrence in clinically localized prostate cancer.
Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
[TBL] [Abstract][Full Text] [Related]
35. Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
Setlur SR; Chen CX; Hossain RR; Ha JS; Van Doren VE; Stenzel B; Steiner E; Oldridge D; Kitabayashi N; Banerjee S; Chen JY; Schäfer G; Horninger W; Lee C; Rubin MA; Klocker H; Demichelis F
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):229-39. PubMed ID: 20056642
[TBL] [Abstract][Full Text] [Related]
36. Impact of prostate-specific antigen on a baseline prostate cancer risk assessment including genetic risk.
Kader AK; Liss MA; Trottier G; Kim ST; Sun J; Zheng SL; Chadwick K; Lockwood G; Xu J; Fleshner NE
Urology; 2015 Jan; 85(1):165-70. PubMed ID: 25530379
[TBL] [Abstract][Full Text] [Related]
37. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.
Kim S; Shin C; Jee SH
Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496
[TBL] [Abstract][Full Text] [Related]
38. Individual and joint performance of DNA methylation profiles, genetic risk score and environmental risk scores for predicting breast cancer risk.
Guan Z; Raut JR; Weigl K; Schöttker B; Holleczek B; Zhang Y; Brenner H
Mol Oncol; 2020 Jan; 14(1):42-53. PubMed ID: 31677238
[TBL] [Abstract][Full Text] [Related]
39. Multi-locus genetic risk score predicts risk for Crohn's disease in Slovenian population.
Zupančič K; Skok K; Repnik K; Weersma RK; Potočnik U; Skok P
World J Gastroenterol; 2016 Apr; 22(14):3777-84. PubMed ID: 27076762
[TBL] [Abstract][Full Text] [Related]
40. Evaluating the effect of multiple genetic risk score models on colorectal cancer risk prediction.
Xin J; Chu H; Ben S; Ge Y; Shao W; Zhao Y; Wei Y; Ma G; Li S; Gu D; Zhang Z; Du M; Wang M
Gene; 2018 Oct; 673():174-180. PubMed ID: 29908285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
